MacroGenics, Inc.
MGNX
$1.74
$0.0955.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 68.59% | -31.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 68.59% | -31.83% | |||
| Cost of Revenue | 485.84% | -80.89% | |||
| Gross Profit | -683.05% | 118.82% | |||
| SG&A Expenses | -13.21% | -61.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.70% | -22.68% | |||
| Operating Income | 13.76% | 19.33% | |||
| Income Before Tax | 11.92% | -183.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.66% | -166.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.66% | -166.10% | |||
| EBIT | 13.76% | 19.33% | |||
| EBITDA | 14.69% | 19.56% | |||
| EPS Basic | 11.89% | -165.35% | |||
| Normalized Basic EPS | 12.15% | 19.35% | |||
| EPS Diluted | 11.89% | -161.31% | |||
| Normalized Diluted EPS | 12.15% | 19.35% | |||
| Average Basic Shares Outstanding | 0.27% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||